Trademark: 88527127
Status Date
Tuesday, August 11, 2020
Registration Number
6126051
Registration Date
Tuesday, August 11, 2020
Filing Date
Monday, July 22, 2019
Published for Opposition
Tuesday, November 19, 2019
5 Therapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
Jan 3, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 3, 2024
Teas Change Of Correspondence Received
Jan 3, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 3, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 11, 2020
Registered-Principal Register
Jul 8, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 7, 2020
Allowed Principal Register - Sou Accepted
Jun 25, 2020
Statement Of Use Processing Complete
Jun 5, 2020
Use Amendment Filed
Jun 25, 2020
Case Assigned To Intent To Use Paralegal
Jun 5, 2020
Teas Statement Of Use Received
Jan 14, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 19, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 19, 2019
Published For Opposition
Oct 30, 2019
Notification Of Notice Of Publication E-Mailed
Oct 16, 2019
Approved For Pub - Principal Register
Oct 10, 2019
Assigned To Examiner
Jul 30, 2019
New Application Office Supplied Data Entered
Jul 25, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
